Antitumor Activity of PEGylated and TEGylated Phenothiazine Derivatives: Structure-Activity Relationship

Int J Mol Sci. 2023 Mar 13;24(6):5449. doi: 10.3390/ijms24065449.

Abstract

The paper aims to investigate the antitumor activity of a series of phenothiazine derivatives in order to establish a structure-antitumor activity relationship. To this end, PEGylated and TEGylated phenothiazine have been functionalized with formyl units and further with sulfonamide units via dynamic imine bonds. Their antitumor activity was monitored in vitro against seven human tumors cell lines and a mouse one compared to a human normal cell line by MTS assay. In order to find the potential influence of different building blocks on antitumor activity, the antioxidant activity, the ability to inhibit farnesyltransferase and the capacity to bind amino acids relevant for tumor cell growth were investigated as well. It was established that different building blocks conferred different functionalities, inducing specific antitumor activity against the tumor cells.

Keywords: anticancer; farnesyltransferase; imines; phenothiazine; poly(ethylene glycol); transimination.

MeSH terms

  • Animals
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Antipsychotic Agents* / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Farnesyltranstransferase
  • Humans
  • Mice
  • Neoplasms*
  • Phenothiazines / chemistry
  • Phenothiazines / pharmacology
  • Polyethylene Glycols / pharmacology
  • Structure-Activity Relationship

Substances

  • Phenothiazines
  • Antipsychotic Agents
  • Farnesyltranstransferase
  • Polyethylene Glycols
  • Antineoplastic Agents